Stay updated on Pembrolizumab First-line in Advanced Merkel Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab First-line in Advanced Merkel Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab First-line in Advanced Merkel Cell Carcinoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page's revision label has been updated to v3.5.4, signaling a newer release of the site. This update does not alter the displayed study details or navigation.
    Difference
    0.0%
    Check dated 2026-05-15T05:34:29.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page metadata shows an interface/release revision bump from v3.5.2 to v3.5.3, with no changes to the underlying ClinicalTrials.gov study content.
    Difference
    0.0%
    Check dated 2026-04-23T21:57:20.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    - Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-16T12:16:24.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    Update of the Italy location entry from Padua, Italy, 35128 to Padova, Italy, 35128.
    Difference
    0.0%
    Check dated 2026-04-09T09:28:58.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Summary
    Added a new resource entry for Cutaneous neuroendocrine carcinoma under the Genetic and Rare Diseases Information Center resources in the study page.
    Difference
    0.1%
    Check dated 2026-04-02T05:51:26.000Z thumbnail image
  8. Check
    52 days ago
    Change Detected
    Summary
    Replaced Napoli, Italy, 80131 with Naples, Italy, 80131 in the locations section.
    Difference
    0.0%
    Check dated 2026-03-26T03:11:15.000Z thumbnail image

Stay in the know with updates to Pembrolizumab First-line in Advanced Merkel Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab First-line in Advanced Merkel Cell Carcinoma Clinical Trial page.